The European Medicines Agencys (EMA) Pharmacovigilance Risk Assessment Committee concluded that no product label update was warranted, based on data from clinical trials, real-world safety monitoring, and electronic health records [45]
Elsevier, Amsterdam, pp 477495 Martnez-Jauand M, Sitges C, Femenia J, Cifre I, Gonzlez S, Chialvo D, Montoya P (2013) Age-of-onset of menopause is associated with enhanced painful and non-painful sensitivity in fibromyalgia
Journal of the German Society of Dermatology
Stopping treatment Weight regain is common after stopping semaglutide treatment
When your fullness signals are stronger, it can feel easier to stick to a nutrition plan that fits your goals